Genmab A/S (GMAB)
USD 20.07
(0.15%)
USD 20.07
(0.15%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 35.28 Billion DKK | 16.55% |
| 2022 | 30.27 Billion DKK | 22.95% |
| 2021 | 24.62 Billion DKK | 16.48% |
| 2020 | 21.14 Billion DKK | 39.61% |
| 2019 | 15.14 Billion DKK | 78.99% |
| 2018 | 8.46 Billion DKK | 28.14% |
| 2017 | 6.6 Billion DKK | 26.05% |
| 2016 | 5.23 Billion DKK | 34.23% |
| 2015 | 3.9 Billion DKK | 36.13% |
| 2014 | 2.86 Billion DKK | 65.56% |
| 2013 | 1.73 Billion DKK | 2.28% |
| 2012 | 1.69 Billion DKK | 8.21% |
| 2011 | 1.56 Billion DKK | -36.96% |
| 2010 | 2.48 Billion DKK | 11.71% |
| 2009 | 2.22 Billion DKK | -31.83% |
| 2008 | 3.25 Billion DKK | -17.68% |
| 2007 | 3.95 Billion DKK | 119.37% |
| 2006 | 1.8 Billion DKK | 31.68% |
| 2005 | 1.37 Billion DKK | 7.75% |
| 2004 | 1.27 Billion DKK | 7.78% |
| 2003 | 1.18 Billion DKK | -25.46% |
| 2002 | 1.58 Billion DKK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 36.68 Billion DKK | 3.94% |
| 2024 Q2 | 38.61 Billion DKK | 5.29% |
| 2023 Q2 | 31.97 Billion DKK | 5.21% |
| 2023 Q4 | 35.28 Billion DKK | 0.14% |
| 2023 FY | 35.28 Billion DKK | 16.55% |
| 2023 Q3 | 35.23 Billion DKK | 10.19% |
| 2023 Q1 | 30.39 Billion USD | 0.38% |
| 2022 Q4 | 30.27 Billion DKK | -1.33% |
| 2022 Q1 | 24.91 Billion DKK | 1.17% |
| 2022 FY | 30.27 Billion DKK | 22.95% |
| 2022 Q2 | 27.47 Billion DKK | 10.28% |
| 2022 Q3 | 30.68 Billion DKK | 11.68% |
| 2021 Q3 | 23.98 Billion DKK | 6.68% |
| 2021 FY | 24.62 Billion DKK | 16.48% |
| 2021 Q2 | 22.48 Billion DKK | 1.23% |
| 2021 Q1 | 22.21 Billion DKK | 5.05% |
| 2021 Q4 | 24.62 Billion DKK | 2.68% |
| 2020 Q1 | 15.3 Billion DKK | 1.05% |
| 2020 Q4 | 21.14 Billion DKK | -1.76% |
| 2020 Q3 | 21.52 Billion DKK | 4.06% |
| 2020 Q2 | 20.68 Billion DKK | 35.16% |
| 2020 FY | 21.14 Billion DKK | 39.61% |
| 2019 FY | 15.14 Billion DKK | 78.99% |
| 2019 Q1 | 8.73 Billion DKK | 3.24% |
| 2019 Q2 | 8.97 Billion DKK | 2.78% |
| 2019 Q3 | 13.33 Billion DKK | 48.49% |
| 2019 Q4 | 15.14 Billion DKK | 13.61% |
| 2018 Q2 | 7.19 Billion DKK | 6.14% |
| 2018 FY | 8.46 Billion DKK | 28.14% |
| 2018 Q1 | 6.78 Billion DKK | 2.73% |
| 2018 Q4 | 8.46 Billion DKK | 14.28% |
| 2018 Q3 | 7.4 Billion DKK | 2.83% |
| 2017 Q3 | 5.89 Billion DKK | -2.21% |
| 2017 FY | 6.6 Billion DKK | 26.05% |
| 2017 Q2 | 6.02 Billion DKK | 11.52% |
| 2017 Q1 | 5.4 Billion DKK | 3.19% |
| 2017 Q4 | 6.6 Billion DKK | 12.01% |
| 2016 Q1 | 3.91 Billion DKK | 0.22% |
| 2016 Q4 | 5.23 Billion DKK | 20.33% |
| 2016 Q3 | 4.35 Billion DKK | 5.44% |
| 2016 Q2 | 4.12 Billion DKK | 5.55% |
| 2016 FY | 5.23 Billion DKK | 34.23% |
| 2015 FY | 3.9 Billion DKK | 36.13% |
| 2015 Q4 | 3.9 Billion DKK | 11.47% |
| 2015 Q3 | 3.5 Billion DKK | 6.62% |
| 2015 Q2 | 3.28 Billion DKK | 3.42% |
| 2015 Q1 | 3.17 Billion DKK | 10.76% |
| 2014 Q3 | 2.83 Billion DKK | 4.16% |
| 2014 Q4 | 2.86 Billion DKK | 1.26% |
| 2014 FY | 2.86 Billion DKK | 65.56% |
| 2014 Q1 | 2.79 Billion DKK | 61.22% |
| 2014 Q2 | 2.71 Billion DKK | -2.64% |
| 2013 Q1 | 1.75 Billion DKK | 3.65% |
| 2013 FY | 1.73 Billion DKK | 2.28% |
| 2013 Q4 | 1.73 Billion DKK | -3.64% |
| 2013 Q3 | 1.79 Billion DKK | 7.22% |
| 2013 Q2 | 1.67 Billion DKK | -4.49% |
| 2012 Q1 | 1.45 Billion DKK | -6.7% |
| 2012 FY | 1.69 Billion DKK | 8.21% |
| 2012 Q3 | 1.77 Billion DKK | 24.99% |
| 2012 Q4 | 1.69 Billion DKK | -4.47% |
| 2012 Q2 | 1.41 Billion DKK | -2.86% |
| 2011 Q1 | 2.2 Billion DKK | -11.24% |
| 2011 Q2 | 2.05 Billion DKK | -6.8% |
| 2011 Q3 | 1.67 Billion DKK | -18.51% |
| 2011 FY | 1.56 Billion DKK | -36.96% |
| 2011 Q4 | 1.56 Billion DKK | -6.48% |
| 2010 Q1 | 2.08 Billion DKK | -6.31% |
| 2010 Q4 | 2.48 Billion DKK | 0.95% |
| 2010 FY | 2.48 Billion DKK | 11.71% |
| 2010 Q3 | 2.45 Billion DKK | 25.75% |
| 2010 Q2 | 1.95 Billion DKK | -6.07% |
| 2009 FY | 2.22 Billion DKK | -31.83% |
| 2009 Q4 | 2.22 Billion DKK | 0.0% |
| 2008 FY | 3.25 Billion DKK | -17.68% |
| 2007 FY | 3.95 Billion DKK | 119.37% |
| 2006 FY | 1.8 Billion DKK | 31.68% |
| 2005 FY | 1.37 Billion DKK | 7.75% |
| 2004 FY | 1.27 Billion DKK | 7.78% |
| 2003 FY | 1.18 Billion DKK | -25.46% |
| 2002 FY | 1.58 Billion DKK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Agenus Inc. | 313.91 Million USD | -11141.65% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -10254.814% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -43147.914% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | -7363.201% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | -62146.878% |
| ChromaDex Corporation | 54.96 Million USD | -64103.843% |
| Pharming Group N.V. | 462.85 Million USD | -7524.218% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -3116865.02% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -7689.447% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -739127.378% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -551032.282% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -186380.692% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -26548.694% |
| AbCellera Biologics Inc. | 1.48 Billion USD | -2271.423% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -14500.15% |
| Alkermes plc | 2.13 Billion USD | -1551.934% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | -821.413% |
| AlloVir, Inc. | 190.79 Million USD | -18395.671% |
| AnaptysBio, Inc. | 452.38 Million USD | -7700.588% |
| Aptorum Group Limited | 20.64 Million USD | -170873.083% |
| Ardelyx, Inc. | 297.57 Million USD | -11758.7% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -4509.615% |
| Opthea Limited | 188.79 Million USD | -18592.077% |
| Bicycle Therapeutics plc | 595.34 Million USD | -5827.497% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -16351.288% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -9274.128% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -5514.306% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -103636.257% |
| Chimerix, Inc. | 212.77 Million USD | -16485.203% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -124717.874% |
| Dyadic International, Inc. | 8.21 Million USD | -429246.475% |
| Elevation Oncology, Inc. | 89.09 Million USD | -39510.062% |
| ESSA Pharma Inc. | 149.12 Million USD | -23564.496% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -6871.121% |
| Fortress Biotech, Inc. | 167.52 Million USD | -20964.79% |
| Fortress Biotech, Inc. | 167.52 Million USD | -20964.79% |
| GlycoMimetics, Inc. | 45.31 Million USD | -77772.341% |
| Structure Therapeutics Inc. | 482.01 Million USD | -7221.11% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -21772.85% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -370571.949% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -5334.796% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -243160.9% |
| Innoviva, Inc. | 1.24 Billion USD | -2737.861% |
| IO Biotech, Inc. | 150.71 Million USD | -23313.925% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -9436.923% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -69507.669% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | -4136.049% |
| ContextLogic Inc. | 423 Million USD | -8242.553% |
| Lantern Pharma Inc. | 43.64 Million USD | -80749.777% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -5409.198% |
| MiMedx Group, Inc. | 239.04 Million USD | -14662.369% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -20547.951% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -65312.99% |
| Onconetix, Inc. | 88.82 Million USD | -39630.268% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -95979.392% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -109150.488% |
| Vaxcyte, Inc. | 1.4 Billion USD | -2406.469% |
| PDS Biotechnology Corporation | 59.39 Million USD | -59319.014% |
| Precigen, Inc. | 151.04 Million USD | -23263.545% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -8427.167% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -91133.195% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -20213.022% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -186380.692% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -21245.875% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -77823.024% |
| Acelyrin, Inc. | 742.69 Million USD | -4651.511% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -47348.033% |
| Senti Biosciences, Inc. | 119.48 Million USD | -29434.498% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -15354.45% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -426972.492% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -7421.228% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -36025.301% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -108796.501% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -12734.744% |
| Molecular Templates, Inc. | 35.38 Million USD | -99634.336% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -8996114.294% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -47780.655% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -7902.622% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -111081.474% |
| Geron Corporation | 394.07 Million USD | -8854.872% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -11361.449% |
| Incyte Corporation | 6.78 Billion USD | -420.325% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -203941.631% |
| Jaguar Health, Inc. | 50.76 Million USD | -69417.168% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -568893.873% |
| MEI Pharma, Inc. | 41.37 Million USD | -85190.634% |
| Novavax, Inc. | 1.85 Billion USD | -1802.021% |
| NextCure, Inc. | 129.41 Million USD | -27167.459% |
| PureTech Health plc | 693.97 Million USD | -4985.068% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -30003.647% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -682512.012% |
| Seer, Inc. | 436.26 Million USD | -7988.817% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -535675.856% |
| Summit Therapeutics Inc. | 202.94 Million USD | -17288.112% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -5657.897% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -20883.624% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -28438.733% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -171672.78% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -349123.157% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -36963.605% |
| Vaxxinity, Inc. | 44.35 Million USD | -79463.953% |
| ADMA Biologics, Inc. | 329.18 Million USD | -10620.209% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -5587244.915% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -22394.98% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -7377.956% |
| CRISPR Therapeutics AG | 2.22 Billion USD | -1482.771% |
| Precision BioSciences, Inc. | 159.78 Million USD | -21985.855% |
| GT Biopharma, Inc. | 14.1 Million USD | -250016.947% |
| ImmuCell Corporation | 43.8 Million USD | -80453.593% |
| Immix Biopharma, Inc. | 19.92 Million USD | -177007.737% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -9176.643% |
| Mesoblast Limited | 669.15 Million USD | -5173.682% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -6131.052% |
| Aptose Biosciences Inc. | 12.92 Million USD | -272980.904% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -159475.594% |
| Soligenix, Inc. | 9.79 Million USD | -360090.117% |
| Century Therapeutics, Inc. | 360.69 Million USD | -9683.721% |
| Kura Oncology, Inc. | 448.93 Million USD | -7760.603% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -12866.794% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -31717.31% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -17101.476% |
| Autolus Therapeutics plc | 375.38 Million USD | -9300.849% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -13923.828% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -9835.414% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -71724.88% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -5237.647% |
| GRI Bio, Inc. | 2.95 Million USD | -1193709.202% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -332651.042% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -20595.54% |
| IGM Biosciences, Inc. | 423.41 Million USD | -8234.455% |
| INmune Bio, Inc. | 57 Million USD | -61809.44% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -15759.797% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -41940.116% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -135019.623% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -512583.427% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -46810.643% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -23864.063% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -21222.143% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -5504.952% |
| Verastem, Inc. | 149.71 Million USD | -23470.312% |
| Abeona Therapeutics Inc. | 64 Million USD | -55037.339% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -6790.31% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -22747.135% |
| Histogen Inc. | 19.07 Million USD | -184920.71% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -155700.128% |
| Surrozen, Inc. | 46.08 Million USD | -76482.031% |
| Organovo Holdings, Inc. | 6.34 Million USD | -555719.814% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -818932.544% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -24401.693% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -298908.643% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -46784.466% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -414126.604% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -9622.318% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -194927.223% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -8118.173% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -279711.16% |
| Apollomics, Inc. | 55.38 Million USD | -63613.507% |
| Amarin Corporation plc | 831.68 Million USD | -4143.078% |
| Turnstone Biologics Corp. | 112.81 Million USD | -31180.415% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -6029.127% |
| Synaptogenix, Inc. | 31.11 Million USD | -113319.611% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -289533.946% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -6338.87% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -600843.998% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -480338.885% |
| Exelixis, Inc. | 2.94 Billion USD | -1099.345% |
| Better Therapeutics, Inc. | 22.94 Million USD | -153711.62% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -9580.446% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -4374.155% |
| NLS Pharmaceutics AG | 1.84 Million USD | -1910883.239% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -442193.756% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -240042.906% |
| Gritstone bio, Inc. | 177.76 Million USD | -19751.043% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -36898.322% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -197461.676% |
| Avid Bioservices, Inc. | 336.55 Million USD | -10385.297% |
| Insmed Incorporated | 1.32 Billion USD | -2553.633% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -366411.586% |
| MediWound Ltd. | 66.45 Million USD | -52998.903% |
| OmniAb, Inc. | 401.98 Million USD | -8678.686% |
| Alector, Inc. | 621.82 Million USD | -5575.051% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -9740.77% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -656073.299% |
| Zai Lab Limited | 1.03 Billion USD | -3305.304% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -7275.631% |
| Aura Biosciences, Inc. | 255.07 Million USD | -13734.754% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -4605.018% |
| Immunic, Inc. | 54.29 Million USD | -64890.147% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -13155.379% |
| Veracyte, Inc. | 1.13 Billion USD | -3001.454% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -298383.047% |
| FibroGen, Inc. | 423.52 Million USD | -8232.133% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -1004426.046% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -744927.293% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -649851.984% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | -209.733% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -400683.646% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -6719.737% |
| TG Therapeutics, Inc. | 329.58 Million USD | -10607.036% |
| Galecto, Inc. | 38.22 Million USD | -92214.333% |
| Calithera Biosciences, Inc. | 28.67 Million USD | -122961.096% |
| Fortrea Holdings Inc. | 4.35 Billion USD | -709.901% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -14890.824% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -141953.78% |
| XBiotech Inc. | 227.24 Million USD | -15429.191% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -36898.322% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -24646.844% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -12242.436% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -27497.776% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -9137.982% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | -2266.78% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -9572.406% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -6726.253% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -189530.675% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -11468.267% |
| NexImmune, Inc. | 8.59 Million USD | -410526.128% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -329236.204% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -205938.386% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | -6.677% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -159210.15% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -20259.547% |
| Ainos, Inc. | 31.84 Million USD | -110726.007% |
| Pluri Inc. | 39.52 Million USD | -89178.215% |
| Prothena Corporation plc | 696.38 Million USD | -4967.477% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -12386.554% |
| Celularity Inc. | 143.88 Million USD | -24425.155% |
| Rallybio Corporation | 115.62 Million USD | -30421.536% |
| Cue Biopharma, Inc. | 61.53 Million USD | -57252.511% |
| MeiraGTx Holdings plc | 458.16 Million USD | -7602.197% |
| Omeros Corporation | 378.26 Million USD | -9229.075% |
| Humacyte, Inc. | 128.22 Million USD | -27421.583% |
| Immunocore Holdings plc | 597 Million USD | -5811.045% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -112792.287% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -51394.236% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -3263.259% |
| CalciMedica, Inc. | 12.18 Million USD | -289510.176% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -13812.478% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -11245.668% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -6142.537% |
| Pulmatrix, Inc. | 33.95 Million USD | -103819.548% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -129897.053% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -24952.89% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -2612.5% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -27005.971% |
| Cytokinetics, Incorporated | 824.31 Million USD | -4181.004% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -166964.337% |
| Nutriband Inc. | 7.51 Million USD | -469346.282% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -44595.646% |
| Vor Biopharma Inc. | 209.82 Million USD | -16718.061% |
| Roivant Sciences Ltd. | 7.22 Billion USD | -388.599% |
| Evogene Ltd. | 51.1 Million USD | -68957.357% |
| ProKidney Corp. | 420.55 Million USD | -8291.115% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -64257.23% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -6358.692% |
| CorMedix Inc. | 82.05 Million USD | -42903.922% |
| BioLineRx Ltd. | 63.92 Million USD | -55103.754% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -8665.994% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -125038.298% |
| Atai Life Sciences N.V. | 293.47 Million USD | -11924.411% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -21532.513% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -27595.459% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -6178.88% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -36386.109% |
| MediciNova, Inc. | 66.26 Million USD | -53150.358% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -40024.847% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -790713.84% |
| GeoVax Labs, Inc. | 9.28 Million USD | -380037.536% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -5899.123% |
| Biomea Fusion, Inc. | 199.92 Million USD | -17550.943% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | -1754.211% |
| Mereo BioPharma Group plc | 66.49 Million USD | -52966.963% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -7174.643% |
| Absci Corporation | 234.48 Million USD | -14949.898% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -482319.686% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -10282.446% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -21276.649% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -6604.831% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -12607.918% |
| Allakos Inc. | 243.61 Million USD | -14385.859% |
| Imunon, Inc. | 21.91 Million USD | -160904.147% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -13594.149% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -5577.882% |
| BioAtla, Inc. | 119.65 Million USD | -29391.551% |
| NLS Pharmaceutics AG | 1.84 Million USD | -1910883.239% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -1095831.677% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -5389.572% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -36684.281% |
| XOMA Corporation | 234.3 Million USD | -14961.395% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -15850.912% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -27941.861% |
| aTyr Pharma, Inc. | 122.06 Million USD | -28809.533% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -22829.378% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -5981.469% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -7095.61% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -31844.708% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -232714.532% |
| Akari Therapeutics, Plc | 4.35 Million USD | -810209.989% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -207027.489% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -1935.978% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -1144165.895% |
| UroGen Pharma Ltd. | 178.31 Million USD | -19690.703% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -7396.559% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -6350097.493% |
| Orgenesis Inc. | 14.55 Million USD | -242402.749% |
| Entera Bio Ltd. | 11.76 Million USD | -299849.001% |
| GH Research PLC | 226.3 Million USD | -15493.902% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -64420.788% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -32746.532% |
| Xencor, Inc. | 952.69 Million USD | -3604.135% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -453266.37% |
| Replimune Group, Inc. | 487.72 Million USD | -7135.474% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -437127.244% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -5342.138% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -1144165.895% |
| Portage Biotech Inc. | 7.77 Million USD | -453544.427% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -790713.84% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -12642.241% |
| OncoCyte Corporation | 74.89 Million USD | -47019.853% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -1735497.428% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -609735.443% |
| Purple Biotech Ltd. | 44.3 Million USD | -79555.546% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -103307.959% |
| scPharmaceuticals Inc. | 94.47 Million USD | -37251.157% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -195461.552% |
| HilleVax, Inc. | 344.43 Million USD | -10145.504% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -1111014.61% |
| Tharimmune, Inc. | 10.94 Million USD | -322280.167% |
| Genprex, Inc. | 10.67 Million USD | -330612.673% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -7011.922% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -36563.134% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -1454516.653% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -847085.208% |
| OKYO Pharma Limited | 1.54 Million USD | -2289514.239% |
| Savara Inc. | 177.56 Million USD | -19773.961% |
| Curis, Inc. | 77.28 Million USD | -45562.638% |
| Daré Bioscience, Inc. | 21.28 Million USD | -165714.508% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -55083.206% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -436320.975% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -182074.384% |
| BeiGene, Ltd. | 5.8 Billion USD | -507.878% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -289890.961% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | -1589.608% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -9758.612% |
| Erasca, Inc. | 395.29 Million USD | -8827.212% |
| bluebird bio, Inc. | 619.16 Million USD | -5599.487% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -816138.447% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | -415.8% |
| DBV Technologies S.A. | 182.98 Million USD | -19185.082% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -816138.447% |
| Moderna, Inc. | 18.42 Billion USD | -91.517% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -193614.662% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -304483.118% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -25422.728% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -4373.117% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -11517.587% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -33849.358% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -7478.813% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -11158.722% |
| MacroGenics, Inc. | 306.82 Million USD | -11401.532% |
| RenovoRx, Inc. | 1.46 Million USD | -2407062.347% |
| Adicet Bio, Inc. | 207.29 Million USD | -16923.565% |
| Prime Medicine, Inc. | 193.85 Million USD | -18104.188% |
| Aditxt, Inc. | 44.57 Million USD | -79061.786% |
| Adagene Inc. | 115.72 Million USD | -30392.832% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -792165.438% |
| Quantum-Si incorporated | 298.25 Million USD | -11732.02% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | -2272.449% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -457656.349% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -9945.804% |
| SciSparc Ltd. | 11.18 Million USD | -315487.551% |
| Vericel Corporation | 353.65 Million USD | -9878.312% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -288855.456% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -61918.665% |
| Generation Bio Co. | 374.75 Million USD | -9316.477% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -13756.973% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -22154.946% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -10237.615% |
| Invivyd, Inc. | 229.18 Million USD | -15297.873% |
| Relay Therapeutics, Inc. | 843.98 Million USD | -4081.26% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -289883.788% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -19248.1% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -172682.021% |
| 2seventy bio, Inc. | 565.42 Million USD | -6141.135% |
| Clene Inc. | 52.34 Million USD | -67321.333% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -59982.411% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -27067.537% |
| GeoVax Labs, Inc. | 9.28 Million USD | -380037.536% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -5298.356% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -33959.076% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -26965.022% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -36074.537% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | -49604.917% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -14448.985% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | -1700.377% |
| Evaxion Biotech A/S | 12.88 Million USD | -273699.699% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -13900.238% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -4588.397% |
| Trevena, Inc. | 40.6 Million USD | -86808.016% |
| Surrozen, Inc. | 46.08 Million USD | -76482.031% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -15524.488% |
| Cingulate Inc. | 3.49 Million USD | -1010630.255% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -212113.603% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -53620.505% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -301912.208% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -13042.185% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -4611.759% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -27931.17% |
| Clearmind Medicine Inc. | 4.32 Million USD | -815945.92% |
| Kronos Bio, Inc. | 213.27 Million USD | -16445.933% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -21985.44% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -412125.297% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -9476.651% |
| Statera Biopharma, Inc. | 21.16 Million USD | -166595.914% |
| ImmunityBio, Inc. | 504.45 Million USD | -6895.512% |
| Korro Bio, Inc. | 221.66 Million USD | -15820.113% |
| Kineta, Inc. | 10.28 Million USD | -343144.821% |
| BioVie Inc. | 25.2 Million USD | -139889.357% |
| Codexis, Inc. | 136.56 Million USD | -25741.199% |
| Celularity Inc. | 143.88 Million USD | -24425.155% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -5454.235% |
| Celcuity Inc. | 191.21 Million USD | -18354.718% |
| Virax Biolabs Group Limited | 5.48 Million USD | -643393.791% |
| Cibus, Inc. | 544.41 Million USD | -6382.051% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -27930.724% |
| IN8bio, Inc. | 33.7 Million USD | -104587.176% |
| Kodiak Sciences Inc. | 479.37 Million USD | -7261.506% |
| Annexon, Inc. | 297.67 Million USD | -11754.915% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -20297.087% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -25570.515% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -167998.89% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | -1080.206% |
| Eyenovia, Inc. | 28.77 Million USD | -122519.067% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -15207.902% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -488396.678% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -57821.085% |
| Arcellx, Inc. | 825.13 Million USD | -4176.77% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -43126.723% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -7533.768% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -114660.976% |
| Moolec Science SA | 24.05 Million USD | -146623.945% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -11278.96% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -34595.703% |
| Royalty Pharma plc | 16.38 Billion USD | -115.415% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -5831.243% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -504402.263% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -293307.108% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -15510.457% |
| Humacyte, Inc. | 128.22 Million USD | -27421.583% |
| 89bio, Inc. | 596.26 Million USD | -5818.302% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -13895.13% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -1907413.514% |
| Genelux Corporation | 27.89 Million USD | -126415.613% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -39371.83% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -15281.229% |
| Notable Labs, Ltd. | 19.54 Million USD | -180489.53% |
| Liquidia Corporation | 120.43 Million USD | -29202.256% |
| Mustang Bio, Inc. | 17.74 Million USD | -198800.913% |
| Immunovant, Inc. | 666.71 Million USD | -5192.99% |
| Quantum-Si incorporated | 298.25 Million USD | -11732.02% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -24338.196% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -65056.942% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -20002.423% |
| Acasti Pharma Inc. | 73.3 Million USD | -48043.247% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -775093.798% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -135019.623% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | -3557.657% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -679852.94% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -154805.404% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -68285.559% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -19430.026% |
| PepGen Inc. | 143.05 Million USD | -24568.652% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -92238.488% |
| United Therapeutics Corporation | 7.16 Billion USD | -392.382% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -183840.579% |
| Solid Biosciences Inc. | 164.93 Million USD | -21295.182% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -600843.998% |
| Immuneering Corporation | 102.58 Million USD | -34299.921% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -818932.544% |
| Silo Pharma, Inc. | 7.74 Million USD | -455468.779% |
| Belite Bio, Inc | 94.64 Million USD | -37186.828% |
| XOMA Corporation | 234.3 Million USD | -14961.395% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -15033.283% |
| Bionomics Limited | 27.64 Million USD | -127531.673% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -8691.392% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -32761.214% |
| uniQure N.V. | 831.68 Million USD | -4143.052% |
| Cassava Sciences, Inc. | 151.66 Million USD | -23168.035% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -792165.438% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -12784.605% |
| Forte Biosciences, Inc. | 38.98 Million USD | -90431.042% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -866288.714% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -95713.309% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -488396.678% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -1004426.046% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -298428.043% |
| Altimmune, Inc. | 210.64 Million USD | -16653.228% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -4436.561% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -32761.214% |
| Compugen Ltd. | 121.33 Million USD | -28984.181% |
| Peak Bio, Inc. | 2.59 Million USD | -1359043.28% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -20377.929% |
| Benitec Biopharma Inc. | 52.21 Million USD | -67490.5% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -10222.677% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -101383.91% |
| Zura Bio Limited | 100.84 Million USD | -34894.001% |
| PolyPid Ltd. | 15.37 Million USD | -229466.745% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -29483.522% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -101383.91% |
| Instil Bio, Inc. | 325.63 Million USD | -10737.146% |
| argenx SE | 4.54 Billion USD | -676.87% |
| Immunome, Inc. | 148.54 Million USD | -23657.237% |
| Verona Pharma plc | 308.12 Million USD | -11352.857% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -40481.193% |
| Shattuck Labs, Inc. | 159.56 Million USD | -22015.891% |
| CervoMed Inc. | 9.97 Million USD | -353762.378% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -18625.326% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -309778.82% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -19570.02% |
| Moolec Science SA | 24.05 Million USD | -146623.945% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -576755.176% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -20304.821% |
| Design Therapeutics, Inc. | 289.64 Million USD | -12083.619% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -48357.261% |
| NeurAxis, Inc. | 509.49 Thousand USD | -6926129.347% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -651228.904% |
| Lumos Pharma, Inc. | 40.63 Million USD | -86737.443% |
| Achilles Therapeutics plc | 161.45 Million USD | -21756.729% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -40481.193% |
| 180 Life Sciences Corp. | 5.25 Million USD | -670860.377% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -50006.635% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -412125.297% |
| Nutriband Inc. | 7.51 Million USD | -469346.282% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -13755.885% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -17606.384% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -46203.732% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -60831.349% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -6602.053% |
| Palisade Bio, Inc. | 14.05 Million USD | -251031.512% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -16680.713% |
| Beam Therapeutics Inc. | 1.45 Billion USD | -2317.528% |
| Neurogene Inc. | 222.57 Million USD | -15755.023% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -5357.447% |
| AEON Biopharma, Inc. | 6.84 Million USD | -515444.193% |
| Sesen Bio, Inc. | 189.17 Million USD | -18554.255% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -12880.244% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -257260.958% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -4422.196% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -13117.151% |
| Athira Pharma, Inc. | 160.24 Million USD | -21921.904% |
| Vaccinex, Inc. | 3.63 Million USD | -971781.025% |
| HCW Biologics Inc. | 28.51 Million USD | -123661.734% |
| XOMA Corporation | 234.3 Million USD | -14961.395% |
| Nektar Therapeutics | 398.03 Million USD | -8765.848% |
| Arvinas, Inc. | 1.3 Billion USD | -2604.967% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -207027.489% |
| Merus N.V. | 458.49 Million USD | -7596.72% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -17167.549% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -19482.806% |
| Rezolute, Inc. | 132.73 Million USD | -26485.654% |
| Clene Inc. | 52.34 Million USD | -67321.333% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -236359.987% |
| BeyondSpring Inc. | 24.8 Million USD | -142148.468% |
| Synlogic, Inc. | 75.55 Million USD | -46609.464% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -297396.206% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -376758.18% |
| Peak Bio, Inc. | 2.59 Million USD | -1359043.28% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -20084.405% |
| Krystal Biotech, Inc. | 818.35 Million USD | -4212.187% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -14576.965% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -4762.164% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -986404.99% |
| MannKind Corporation | 475.19 Million USD | -7326.168% |
| Ikena Oncology, Inc. | 192.09 Million USD | -18270.885% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -263762.719% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -30180.85% |
| Gossamer Bio, Inc. | 311.91 Million USD | -11213.623% |
| CohBar, Inc. | 16.36 Million USD | -215528.242% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -100258.331% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -482319.686% |
| Legend Biotech Corporation | 1.84 Billion USD | -1808.949% |
| Mural Oncology plc | 301.74 Million USD | -11594.974% |
| Biora Therapeutics, Inc. | 31.21 Million USD | -112951.418% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -621140.915% |
| Disc Medicine, Inc. | 367.99 Million USD | -9489.506% |
| Champions Oncology, Inc. | 26.13 Million USD | -134941.329% |
| REGENXBIO Inc. | 573.97 Million USD | -6048.231% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -1302997.946% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -22757.643% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -292134.41% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -10278.049% |
| Vaxart, Inc. | 91.83 Million USD | -38328.618% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -58809.37% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -23691.367% |
| Cellectis S.A. | 334.27 Million USD | -10457.035% |
| Longeveron Inc. | 12.17 Million USD | -289676.646% |
| Repare Therapeutics Inc. | 253.9 Million USD | -13798.724% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | -980.967% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -17470.091% |
| Revolution Medicines, Inc. | 2.08 Billion USD | -1589.608% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -2171530.769% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -12607.095% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -21536.685% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -25334.613% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -138168.944% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | -55.252% |
| Denali Therapeutics Inc. | 1.15 Billion USD | -2958.192% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -288855.456% |
| Veru Inc. | 50.59 Million USD | -69646.724% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -77368.004% |
| Cingulate Inc. | 3.49 Million USD | -1010630.255% |
| Passage Bio, Inc. | 150.54 Million USD | -23340.832% |
| Context Therapeutics Inc. | 16.06 Million USD | -219594.84% |
| Exicure, Inc. | 11.58 Million USD | -304640.933% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -9284.174% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -21731.578% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -201874.588% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -10505.419% |
| Nuvalent, Inc. | 732.38 Million USD | -4718.374% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -236040.347% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -39305.275% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -248571.693% |
| OmniAb, Inc. | 401.98 Million USD | -8678.686% |
| Anew Medical, Inc. | 19.45 Million USD | -181278.933% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -131937.219% |
| Lipocine Inc. | 23 Million USD | -153323.284% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -25141.225% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -11448.77% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -41940.116% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -28934.886% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -444625.898% |
| Sage Therapeutics, Inc. | 882.27 Million USD | -3899.764% |
| Ocugen, Inc. | 64.54 Million USD | -54571.79% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -28235.247% |
| Q32 Bio Inc. | 306.11 Million USD | -11427.87% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -838516.92% |
| Alumis Inc. Common Stock | 89.61 Million USD | -39279.771% |
| Equillium, Inc. | 50.53 Million USD | -69737.72% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -46829.982% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -85400.332% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -2074682.477% |
| Galera Therapeutics, Inc. | 26.14 Million USD | -134894.836% |
| Evelo Biosciences, Inc. | 64.44 Million USD | -54661.72% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -946718.623% |
| Dominari Holdings Inc. | 57.55 Million USD | -61210.33% |
| Edesa Biotech, Inc. | 8.89 Million USD | -396832.119% |
| vTv Therapeutics Inc. | 11.01 Million USD | -320184.988% |
| Bio-Techne Corporation | 2.81 Billion USD | -1154.412% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -3665.694% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -4248.892% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -12609.2% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -84521.841% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -5186.045% |
| Nkarta, Inc. | 378.88 Million USD | -9213.908% |
| BioCardia, Inc. | 2.98 Million USD | -1181319.484% |
| Iterum Therapeutics plc | 26.25 Million USD | -134288.21% |